Literature DB >> 7678092

Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study.

L D Truong1, D Kadmon, B K McCune, K C Flanders, P T Scardino, T C Thompson.   

Abstract

Prostate tissue samples from patients with prostatic carcinoma (PC) and/or benign prostatic hyperplasia (BPH) were examined for expression of transforming growth factor-beta 1 (TGF-beta 1) using an immunohistochemical technique. Tissues were stained with CC and LC antisera, which react with extracellular and intracellular TGF-beta 1, respectively. All PC and BPH tissues showed positive extracellular staining; however, CC-immunoreactive material was significantly more extensive in PC compared with BPH, the average positively staining areas being 59% and 26%, respectively. This differential staining pattern was evident in cases in which areas of PC were located adjacent to areas of BPH. LC staining was identified exclusively intracellularly involving both stromal and epithelial cells in cases of PC as well as BPH. However, while stromal cell staining was more pronounced in BPH, epithelial cell staining tended to be more extensive and more intense in PC. The findings suggest that TGF-beta 1 may be biologically important in the development of PC and BPH.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678092     DOI: 10.1016/0046-8177(93)90055-l

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  22 in total

1.  BTS guidelines for the investigation of a unilateral pleural effusion in adults.

Authors:  N A Maskell; R J A Butland
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 2.  Reversal of tumor-induced immunosuppression by TGF-beta inhibitors.

Authors:  Slawomir Wojtowicz-Praga
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

Review 3.  Tumor markers in prostate cancer I: blood-based markers.

Authors:  Shahrokh F Shariat; Axel Semjonow; Hans Lilja; Caroline Savage; Andrew J Vickers; Anders Bjartell
Journal:  Acta Oncol       Date:  2011-06       Impact factor: 4.089

4.  Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer.

Authors:  Shahrokh F Shariat; Eduardo I Canto; Michael W Kattan; Kevin M Slawin
Journal:  Rev Urol       Date:  2004

5.  Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine.

Authors:  D L Shawler; R M Bartholomew; M A Garrett; R J Trauger; O Dorigo; C Van Beveren; A Marchese; F Ferre; C Duffy; D J Carlo; L A Sherman; D P Gold; R E Sobol
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

Review 6.  The role of fibroblasts in tumor behavior.

Authors:  M Grégoire; B Lieubeau
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

7.  PPARδ promotes oncogenic redirection of TGF-β1 signaling through the activation of the ABCA1-Cav1 pathway.

Authors:  Nam-Gu Her; Seong-In Jeong; Kyucheol Cho; Tae-Kyu Ha; Jikhyon Han; Kyung-Phil Ko; Soon-Ki Park; Jin-Hee Lee; Min-Goo Lee; Byung-Kyu Ryu; Sung-Gil Chi
Journal:  Cell Cycle       Date:  2013-04-17       Impact factor: 4.534

Review 8.  Prostate cancer progression. Implications of histopathology.

Authors:  J L Ware
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

9.  Paracrine communication between malignant and non-malignant prostate epithelial cells in culture alters growth rate, matrix protease secretion and in vitro invasion.

Authors:  Andrea H Greiff; William M Fischer; Inder Sehgal
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 10.  Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer.

Authors:  J L Ware
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.